Attention Deficit Hyperactivity disorder. Disturbance of activity and attention
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Written and oral informed consent by parents of participants Age between 6 to 18 years The diagnosis of ADHD according to DSM-5 criteria by a child and adolescent psychiatrist Being on the standard treatment with Methylphenidate or Methylphenidate and Clonidine without any dose changes from 2 weeks before and during the study period
Exclusion criteria
Exclusion criteria: Patients with mental retardation, epilepsy, pervasive developmental disorders, schizophrenia, manic episode, mood and anxiety disorders and drug or organic disorder induced hyperactivity Any dose change in the standard drug therapy during the study period
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ADHD Rating Scale score. Timepoint: Before the intervention and 3 weeks after the intervention. Method of measurement: ADHD Rating Scale-IV questionnaire.;Continuous Performance Test score. Timepoint: Before the intervention and 3 weeks after the intervention. Method of measurement: Continuous Performance Test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Mashhad University of Medical Sciences